Potential angiotensin I converting enzyme inhibitory peptides from gluten hydrolysate: Biochemical characterization and molecular docking study

[1]  J. Chamani,et al.  Purification and biochemical characterization of angiotensin I-converting enzyme (ACE) from ostrich lung: The effect of 2,2,2-trifluoroethanol on ACE conformation and activity , 2013 .

[2]  Joseph Audie,et al.  Advances in the Prediction of Protein–Peptide Binding Affinities: Implications for Peptide‐Based Drug Discovery , 2013, Chemical biology & drug design.

[3]  A. Camarca,et al.  Repertoire of gluten peptides active in celiac disease patients: perspectives for translational therapeutic applications. , 2012, Endocrine, metabolic & immune disorders drug targets.

[4]  J. Chamani,et al.  Purification and characterisation of angiotensin I converting enzyme inhibitory peptides from lysozyme hydrolysates , 2012 .

[5]  Se-kwon Kim,et al.  Marine fish-derived bioactive peptides as potential antihypertensive agents. , 2012, Advances in food and nutrition research.

[6]  Philippe Vayer,et al.  Toward in silico structure-based ADMET prediction in drug discovery. , 2012, Drug discovery today.

[7]  W. Burns,et al.  Angiotensin-converting enzyme 2 is a key modulator of the renin–angiotensin system in cardiovascular and renal disease , 2011, Current opinion in nephrology and hypertension.

[8]  David S. Wishart,et al.  DrugBank 3.0: a comprehensive resource for ‘Omics’ research on drugs , 2010, Nucleic Acids Res..

[9]  A. Tossi.  Design and Engineering Strategies for Synthetic Antimicrobial Peptides , 2011 .

[10]  M. Khrestchatisky,et al.  Synthetic therapeutic peptides: science and market. , 2010, Drug discovery today.

[11]  Suzanne Skolnik,et al.  Recent Advances in Physicochemical and ADMET Profiling in Drug Discovery , 2009, Chemistry & biodiversity.

[12]  J. Després,et al.  Visceral Obesity: The Link Among Inflammation, Hypertension, and Cardiovascular Disease , 2009, Hypertension.

[13]  G. Bakris,et al.  The message for World Kidney Day 2009: hypertension and kidney disease: a marriage that should be prevented. , 2009, Kidney international.

[14]  Eric A. Decker,et al.  Antioxidant Activity of Proteins and Peptides , 2008, Critical reviews in food science and nutrition.

[15]  Yong-hui Shi,et al.  Novel angiotensin I‐converting enzyme inhibitory peptides isolated from Alcalase hydrolysate of mung bean protein , 2006, Journal of peptide science : an official publication of the European Peptide Society.

[16]  O. Kocy,et al.  Inhibition of angiotensin-converting enzyme by analogs of peptides fromBothrops jararaca venom , 1973, Experientia.

[17]  R. Natesh,et al.  Structure of angiotensin I-converting enzyme. , 2004, Cellular and molecular life sciences : CMLS.

[18]  P. Shewry,et al.  Genetics of wheat gluten proteins. , 2003, Advances in genetics.

[19]  A. Fenves,et al.  Clinical pharmacology of antihypertensive drugs. , 2002, Cardiology clinics.

[20]  R. Fitzgerald,et al.  Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme , 2000, British Journal of Nutrition.

[21]  R W Piepho,et al.  Overview of the angiotensin-converting-enzyme inhibitors. , 2000, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[22]  H. Fujita,et al.  Classification and Antihypertensive Activity of Angiotensin I-Converting Enzyme Inhibitory Peptides Derived from Food Proteins , 2000 .

[23]  G. Mancia,et al.  Task force V: White-coat hypertension , 1999 .

[24]  G. Mancia,et al.  Blood Pressure Monitoring. Task force V: White-coat hypertension. , 1999, Blood pressure monitoring.

[25]  G. Pepper.  Pharmacology of antihypertensive drugs. , 1999, Journal of obstetric, gynecologic, and neonatal nursing : JOGNN.

[26]  N. Yamamoto,et al.  Antihypertensive peptides derived from food proteins. , 1997, Biopolymers.

[27]  R. Wood.  Bronchospasm and cough as adverse reactions to the ACE inhibitors captopril, enalapril and lisinopril. A controlled retrospective cohort study. , 1995, British journal of clinical pharmacology.

[28]  M. Yoshikawa,et al.  Opioid peptides derived from wheat gluten: Their isolation and characterization , 1992, FEBS letters.

[29]  C. Johnston,et al.  Characterization of cardiac angiotensin converting enzyme (ACE) and in vivo inhibition following oral quinapril to rats , 1990, British journal of pharmacology.

[30]  P. Bünning.  The catalytic mechanism of angiotensin converting enzyme. , 1983, Clinical and experimental hypertension. Part A, Theory and practice.

[31]  K. Silberbauer,et al.  Acute hypotensive effect of captopril in man modified by prostaglandin synthesis inhibition. , 1982, British journal of clinical pharmacology.

[32]  J. Riordan,et al.  A continuous spectrophotometric assay for angiotensin converting enzyme. , 1979, Analytical biochemistry.